The objective of this study is to investigate feasibility and safety of prostate artery radioembolization in a canine model. This project agreement will compile a comprehensive preclinical report for submission to the FDA. This will include all data and analysis from the preclinical study. Additionally, a clinical study protocol for a human IDE study for prostate artery embolization in prostate cancer patients will be developed using the data acquired from the preclinical canine study.
|Effective start/end date||10/19/20 → 6/30/21|
- Biocompatibles UK Ltd. (Agmt 10/19/20)